looksthread
Pharmaceutical
PharmaceuticalBody Prescription

Growth Hormone

Also known as HGH, somatropin, rhGH

A real, approved hormone with a narrow legitimate use and an enormous grey market. Genuine deficiency aside, the cosmetic case is weak and the risks are not.

Evidence
Strong
Typical cost
$400 – $3k
Permanence
Ongoing use
Timeline
Body composition changes over 3–6 months. Structural side effects accumulate over years.

US $400–3,000/month legitimately. Grey-market pricing is lower and quality is unverifiable.

How it works

Recombinant human growth hormone acts on the liver to raise IGF-1, which drives cell proliferation, lipolysis and, in children with open growth plates, longitudinal bone growth. In adults the plates are fused, so it cannot increase height — it changes body composition and soft tissue instead.

How it's used

Legitimately prescribed for diagnosed GH deficiency, Turner syndrome, and some paediatric growth disorders, after stimulation testing by an endocrinologist. Adult use for physique or anti-ageing is off-label, and in several countries distributing it for those purposes is a criminal offence. If you suspect deficiency, ask for testing rather than sourcing it.

Trade-offs

In favour

  • Genuinely corrects diagnosed deficiency
  • Reduces fat mass and modestly increases lean mass
  • Improves quality of life in true adult GH deficiency

Against

  • Cannot increase adult height — growth plates are fused
  • Extremely expensive legitimately, and the grey market is heavily counterfeited
  • Effects reverse when stopped
  • Banned in essentially all tested sport

Risks and side effects

Read before deciding
  • Acromegaly-type changes with sustained supraphysiological use: brow ridge and jaw growth, enlarged hands and feet, coarsened features — these are permanent
  • Insulin resistance and new-onset type 2 diabetes
  • Carpal tunnel syndrome, oedema, joint pain
  • Cardiomyopathy with prolonged high dosing
  • IGF-1 elevation and its theoretical cancer-promotion risk
  • Counterfeit product with unknown contents is the norm outside pharmacy channels

How good is the evidence?

Strong
Good trial evidence with consistent findings.

Strong evidence in diagnosed deficiency. Evidence for cosmetic or anti-ageing use in healthy adults is weak, and the risk profile is well characterised.

Sources

Sources point to guideline bodies and literature searches rather than single papers, so they stay accurate as the evidence moves.

More in Pharmaceutical

Growth Hormone · looksthread